White Paper Agentic AI in Specialty Pharma Access This white paper explores what agentic AI means for the specialty pharma access function, why the current moment represents a… Read More
White Paper Why Consent Management is Biopharma’s Blind Spot In specialty and rare disease, patient consent is collected across hub services, specialty pharmacies, patient services teams, and digital channels…. Read More
White Paper The Omnichannel Gap: Building the CRM of the Future for Patient Services Specialty therapies demand more than just tracking—they require a total patient management system. Most traditional CRMs are built to manage… Read More
White Paper Transforming Data Aggregation in Oncology, Specialty, and Rare Disease Unlock transparent, high‑impact data aggregation for oncology, specialty, and rare disease. In specialty and rare disease, the biggest data challenge… Read More
White Paper Thriving in Turbulence: Strategic Adaptation in the Evolving Specialty and Rare Market The Five Market Trends Shaping 2026 In specialty and rare disease markets, even small shifts in demand, coverage, or supply… Read More
White Paper Quantifying Connection: Measuring Partner Impact and CRM ROI Across the Enterprise Discover the measurable value of CRM with our new white paper: Quantifying Connection—Measuring Partner Impact and CRM ROI Across the… Read More
White Paper From Barriers to Breakthroughs: Reimagining Patient Support ROI with AI Discover Breakthroughs in Patient Support ROI Struggling with complex patient journeys and mounting workloads? See how Claritas Rx is helping… Read More
White Paper One Month to $241K: Real-Time Market Access Insights Deliver Measurable Gains Accelerating market access data delivery from multi-day lags to next-day reporting enables earlier patient interventions, reduces therapy abandonment, and can… Read More
White Paper From Prescription to Abandonment—Why 31% of Specialty Medications Go Unfilled This Claritas Rx white paper analyzes over 85,000 specialty prescriptions to reveal the key reasons for prescription abandonment during pharmacy… Read More
White Paper Understanding Why Patients Abandon Prescribed Treatments Navigating the patient treatment journey is like solving a complex puzzle for the pharmaceutical industry. At every turn, there are… Read More
